Literature DB >> 24102679

Synaptic vesicle protein 2A: basic facts and role in synaptic function.

Julieta Griselda Mendoza-Torreblanca1, América Vanoye-Carlo, Bryan Víctor Phillips-Farfán, Liliana Carmona-Aparicio, Gisela Gómez-Lira.   

Abstract

In recent years, there has been considerable interest in determining the function of synaptic vesicle protein 2A and its role as a target for antiepileptic drugs. Although it is known that synaptic vesicle protein 2A is involved in normal synaptic vesicle function, its participation in synaptic vesicle cycling and neurotransmitter release in normal and pathological conditions is unclear. However, the experimental evidence suggests that synaptic vesicle protein 2A could be a vesicular transporter, regulate synaptic exocytosis as a gel matrix, or modulate synaptotagmin-1 activity. This review describes and discusses the participation of synaptic vesicle protein 2A in synaptic modulation in normal and pathological conditions.
© 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  epilepsy; neurotransmitter; neurotransmitter release; synapse; synaptic proteins

Mesh:

Substances:

Year:  2013        PMID: 24102679     DOI: 10.1111/ejn.12360

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  36 in total

1.  Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A).

Authors:  Songye Li; Zhengxin Cai; Wenjie Zhang; Daniel Holden; Shu-Fei Lin; Sjoerd J Finnema; Anupama Shirali; Jim Ropchan; Stephane Carre; Joel Mercier; Richard E Carson; Nabeel Nabulsi; Yiyun Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-07       Impact factor: 9.236

2.  Radiosynthesis of (11)C-Levetiracetam: A Potential Marker for PET Imaging of SV2A Expression.

Authors:  Hancheng Cai; Thomas J Mangner; Otto Muzik; Ming-Wei Wang; Diane C Chugani; Harry T Chugani
Journal:  ACS Med Chem Lett       Date:  2014-08-19       Impact factor: 4.345

Review 3.  Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Authors:  Stefanie M A Willekens; Donatienne Van Weehaeghe; Philip Van Damme; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-08       Impact factor: 9.236

4.  An Epilepsy-Associated SV2A Mutation Disrupts Synaptotagmin-1 Expression and Activity-Dependent Trafficking.

Authors:  Callista B Harper; Christopher Small; Elizabeth C Davenport; Darryl W Low; Karen J Smillie; Ramón Martínez-Mármol; Frédéric A Meunier; Michael A Cousin
Journal:  J Neurosci       Date:  2020-04-27       Impact factor: 6.167

5.  Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.

Authors:  Sjoerd J Finnema; Nabeel B Nabulsi; Joël Mercier; Shu-Fei Lin; Ming-Kai Chen; David Matuskey; Jean-Dominique Gallezot; Shannan Henry; Jonas Hannestad; Yiyun Huang; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-09       Impact factor: 6.200

6.  [18F]BIBD-181: A Novel Positron Emission Tomography Tracer Specific for Synaptic Vesicle Glycoprotein 2A.

Authors:  Zeng Jiang; Xuebo Cheng; Hualong Chen; Wei Zheng; Yuli Sun; Ziyue Yu; Tingyu Yang; Lu Zhang; Di Fan; Zhihao Yang; Yajing Liu; Lin Ai; Zehui Wu
Journal:  ACS Med Chem Lett       Date:  2022-03-30       Impact factor: 4.632

7.  Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.

Authors:  Mohanan Valiya Veettil; Gayathri Krishna; Arunava Roy; Anandita Ghosh; Dipanjan Dutta; Binod Kumar; Sayan Chakraborty; Thoppil Raveendran Anju; Neelam Sharma-Walia; Bala Chandran
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

8.  Phosphorylation of synaptic vesicle protein 2A at Thr84 by casein kinase 1 family kinases controls the specific retrieval of synaptotagmin-1.

Authors:  Ning Zhang; Sarah L Gordon; Maximilian J Fritsch; Noor Esoof; David G Campbell; Robert Gourlay; Srikannathasan Velupillai; Thomas Macartney; Mark Peggie; Daan M F van Aalten; Michael A Cousin; Dario R Alessi
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

9.  Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.

Authors:  Itzel Jatziri Contreras-García; Gisela Gómez-Lira; Bryan Víctor Phillips-Farfán; Luz Adriana Pichardo-Macías; Mercedes Edna García-Cruz; Juan Luis Chávez-Pacheco; Julieta G Mendoza-Torreblanca
Journal:  Brain Sci       Date:  2021-04-23

10.  The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer's Disease: Implications for Treatment.

Authors:  Yanyan Kong; Lin Huang; Weihao Li; Xuanting Liu; Yinping Zhou; Cuiping Liu; Shibo Zhang; Fang Xie; Zhengwei Zhang; Donglang Jiang; Weiyan Zhou; Ruiqing Ni; Chencheng Zhang; Bomin Sun; Jiao Wang; Yihui Guan
Journal:  Front Cell Dev Biol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.